QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=1BD4BA3675BB5A1AFF2AF3E4C72D7937;jsessionid=D532B8280E1FEC696D04F94FFCB25378;jsessionid=AAE5F35545F34C913DFFB22CF3676410;jsessionid=471F26B25CE5BBB2CBA9BDB3C68CF5DA;jsessionid=3A67DD7DE398A822F7A39E28C698B69A (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=1BD4BA3675BB5A1AFF2AF3E4C72D7937;jsessionid=D532B8280E1FEC696D04F94FFCB25378;jsessionid=AAE5F35545F34C913DFFB22CF3676410;jsessionid=471F26B25CE5BBB2CBA9BDB3C68CF5DA;jsessionid=3A67DD7DE398A822F7A39E28C698B69A